Canadian Mushroom Startup Maia Farms Expands from Meat Alternatives to Functional Health Ingredients
- Gauri Khanna
- 22 hours ago
- 3 min read
Too long to read? Go for the highlights below.
Vancouver-based Maia Farms raised C$3.75 million to expand production of mushroom and mycelium ingredients targeting functional health applications beyond traditional protein markets
The company's fermentation-derived mycelium products achieve protein content of 66 grammes per 100 grammes with digestibility score comparable to animal proteins
Current co-manufacturing capacity enables production of 200,000 kg annually, with ingredients already incorporated into over 20 products across North America
The alternative protein sector increasingly confronts a fundamental question: should companies position their offerings primarily as meat substitutes or as distinct nutritional ingredients with broader applications? Maia Farms, a Vancouver-based startup, has chosen the latter path.
From Space Food to Commercial Scale
Founded in 2021 by farmer Gavin Schneider, engineer Ashton Ostrander, and neuroscientist Sean Lacoursiere following success in a space food competition, the company has developed two proprietary manufacturing processes. The first employs dry extrusion to create shelf-stable textured mushroom ingredients marketed as Maia Form. The second utilises fermentation to produce high-moisture mycelium pulp called Maia Fresh.

These processes have been scaled across multiple North American locations, positioning the company to deliver 200,000 kilogrammes annually through current co-manufacturing partnerships. The recent C$3.75 million seed funding round, led by Active Impact Investments with participation from Nya Ventures, Ag-West Bio, PIC Investment Group, and Deep Checks, brings total capitalisation to C$8.8 million including non-dilutive sources.
Co-founder and chief executive Schneider indicated the capital will support commercial expansion, team development, production scaling, and research laboratory expansion. Notably, the company aims to establish additional co-manufacturing options globally to reduce lead times and transportation costs.
Nutritional Profile and Applications
Maia Farms' mycelium extrudates, blended with pea protein, demonstrate a PDCAAS (Protein Digestibility Corrected Amino Acid Score) of 0.92: a metric assessing protein quality based on amino acid requirements and digestibility. For context, scores approaching 1.0 indicate proteins meeting human nutritional needs efficiently, with eggs and whey achieving the maximum score.

The products contain 66 grammes of protein per 100 grammes, positioning them competitively against conventional protein sources. More significantly, the company reports achieving cost parity with beef and chicken mince for a four-ounce serving at current capacity.
Over the past year, Maia ingredients appeared in over 20 products including soups, chilis, curries, sausages, spice mixes, and burrito bowls. The company recently received recognition as Best Meat Solution in December 2025, though Schneider emphasised the transition beyond positioning as mere protein providers.
Strategic Pivot Towards Functional Ingredients
The strategic shift centres on functional health applications rather than meat replacement. Schneider characterised this transition as moving from farm to pharmacy, targeting customers prioritising health through daily food consumption. The company plans to launch a portfolio of mycelium-based specialty ingredients offering unique functionality at small inclusion rates.
This approach acknowledges mushrooms' bioactive compounds beyond protein content (including beta-glucans, ergothioneine, and various polyphenols) which research associates with immune modulation, antioxidant activity, and metabolic benefits.
The company maintains partnerships addressing food security, including a centre-of-plate option with The Greater Vancouver Food Bank. Additionally, collaboration with Phytokana Ingredients on a C$24 million project backed by Protein Industries Canada explores upcycling fava bean byproducts as fermentation media components, potentially improving cost-effectiveness whilst demonstrating circular economy principles.
Market Positioning and Future Trajectory
Mike Winterfield, managing partner at Active Impact Investments, noted that Maia demonstrated capability to outperform conventional options on cost, nutrition, and taste through fermentation and extrusion-based processes. Whether this thesis proves correct depends on scaling challenges, regulatory considerations for functional claims, and consumer acceptance of mushroom-derived ingredients across diverse applications.

Schneider positioned the company as food-first and planet-forward rather than anti-animal or anti-plant, emphasising agility and technological integration. The founding narrative (three specialists from disparate backgrounds converging on mushroom biotechnology) reflects broader trends of interdisciplinary approaches addressing food system challenges.
The trajectory from winning a space food competition to securing nearly C$9 million in funding illustrates commercial interest in fungal fermentation platforms, though translating current capacity into sustainable market share requires navigating competitive pressures from established ingredient suppliers and emerging mycelium companies pursuing similar strategies.

